Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies

References

• Corey M McLaughlin FJ Williams M Levison H A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto J Clin Epidemiol 1988 41 6 583 591 3260274
   PubMed Web of Science ®Google Scholar
• Kerem E Reisman J Corey M Canny GJ Levison H Prediction of mortality in patients with cystic fibrosis N Engl J Med 1992 326 18 1187 1191 1285737
   PubMed Web of Science ®Google Scholar
• Kraemer R Rudeberg A Hadorn B Rossi E Relative underweight in cystic fibrosis and its prognostic value Acta Paediatr Scand 1978 67 1 33 37 626067
   PubMed Web of Science ®Google Scholar
• Borowitz D Baker RD Stallings V Consensus report on nutrition for pediatric patients with cystic fibrosis J Pediatr Gastroenterol Nutr 2002 35 3 246 259 12352509
   PubMed Web of Science ®Google Scholar
• Cohen-Cymberknoh M Shoseyov D Kerem E Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life Am J Respir Crit Care Med 2011 183 11 1463 1471 21330455
   PubMed Web of Science ®Google Scholar
• Lai HJ Classification of nutritional status in cystic fibrosis Curr Opin Pulm Med 2006 12 6 422 427 17053492
   PubMed Web of Science ®Google Scholar
• Pedreira CC Robert RG Dalton V Association of body composition and lung function in children with cystic fibrosis Pediatr Pulmonol 2005 39 3 276 280 15668934
   PubMed Web of Science ®Google Scholar
• Quinton HB O’Connor GT Current issues in quality improvement in cystic fibrosis Clin Chest Med 2007 28 2 459 472 17467560
   PubMed Web of Science ®Google Scholar
• Stallings VA Stark LJ Robinson KA Feranchak AP Quinton H Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review J Am Diet Assoc 2008 108 5 832 839 18442507
   PubMed Web of Science ®Google Scholar
• Steinkamp G Wiedemann B Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project Thorax 2002 57 7 596 601 12096202
   PubMed Web of Science ®Google Scholar
• Tiddens HA Quality improvement in your CF centre: taking care of care J Cyst Fibros 2009 8 Suppl 1 S2 S5 19460683
   PubMedGoogle Scholar
• Sinaasappel M Stern M Littlewood J Nutrition in patients with cystic fibrosis: a European Consensus J Cyst Fibros 2002 1 2 51 75 15463811
   PubMedGoogle Scholar
• Borowitz D Robinson KA Rosenfeld M Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis J Pediatr 2009 155 6 Suppl S73 S93 19914445
   PubMed Web of Science ®Google Scholar
• Colombo C Costantini D Zazzeron L Benefits of breastfeeding in cystic fibrosis: a single-centre follow-up survey Acta Paediatr 2007 96 8 1228 1232 17590186
   PubMed Web of Science ®Google Scholar
• Ellis L Kalnins D Corey M Brennan J Pencharz P Durie P Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study J Pediatr 1998 132 2 270 276 9506640
   PubMed Web of Science ®Google Scholar
• Pencharz PB Durie PR Pathogenesis of malnutrition in cystic fibrosis, and its treatment Clin Nutr 2000 19 6 387 394 11104588
   PubMed Web of Science ®Google Scholar
• Efrati O Mei-Zahav M Rivlin J Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease J Pediatr Gastroenterol Nutr 2006 42 2 222 228 16456419
   PubMed Web of Science ®Google Scholar
• Walker SA Gozal D Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings J Pediatr Gastroenterol Nutr 1998 27 1 53 56 9669726
   PubMed Web of Science ®Google Scholar
• Williams SG Ashworth F McAlweenie A Poole S Hodson ME Westaby D Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis Gut 1999 44 1 87 90 9862831
   PubMed Web of Science ®Google Scholar
• Britton LJ Thrasher S Gutierrez H Creating a culture of improvement: experience of a pediatric cystic fibrosis center J Nurs Care Qual 2008 23 2 115 120 18344776
   PubMed Web of Science ®Google Scholar
• Feranchak AP Sontag MK Wagener JS Hammond KB Accurso FJ Sokol RJ Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen J Pediatr 1999 135 5 601 610 10547249
   PubMed Web of Science ®Google Scholar
• Hakim F Kerem E Rivlin J Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis J Pediatr Gastroenterol Nutr 2007 45 3 347 353 17873748
   PubMed Web of Science ®Google Scholar
• Drury D Grey VL Ferland G Gundberg C Lands LC Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis J Cyst Fibros 2008 7 5 457 459 18511355
   PubMed Web of Science ®Google Scholar
• Nicolaidou P Stavrinadis I Loukou I The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis Eur J Pediatr 2006 165 8 540 545 16622660
   PubMed Web of Science ®Google Scholar
• Wilson DC Rashid M Durie PR Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination J Pediatr 2001 138 6 851 855 11391328
   PubMed Web of Science ®Google Scholar
• Beharry S Ellis L Corey M Marcon M Durie P How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 2002 141 1 84 90 12091856
   PubMed Web of Science ®Google Scholar
• Borowitz D Baker SS Duffy L Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis J Pediatr 2004 145 3 322 326 15343184
   PubMed Web of Science ®Google Scholar
• Cohen JR Schall JI Ittenbach RF Zemel BS Stallings VA Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis J Pediatr Gastroenterol Nutr 2005 40 4 438 444 15795591
   PubMed Web of Science ®Google Scholar
• Dorlochter L Aksnes L Fluge G Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway Eur J Nutr 2002 41 4 148 152 12242582
   PubMed Web of Science ®Google Scholar
• Walkowiak J Nousia-Arvanitakis S Cade A Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis J Cyst Fibros 2002 1 4 260 264 15463824
   PubMedGoogle Scholar
• Daftary A Acton J Heubi J Amin R Fecal elastase-1: utility in pancreatic function in cystic fibrosis J Cyst Fibros 2006 5 2 71 76 16603421
   PubMed Web of Science ®Google Scholar
• Kalnins D Durie PR Pencharz P Nutritional management of cystic fibrosis patients Curr Opin Clin Nutr Metab Care 2007 10 3 348 354 17414506
   PubMed Web of Science ®Google Scholar
• Cade A Walters MP McGinley N Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis Pediatr Pulmonol 2000 29 3 172 176 10686036
   PubMed Web of Science ®Google Scholar
• Loser C Mollgaard A Folsch UR Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test Gut 1996 39 4 580 586 8944569
   PubMed Web of Science ®Google Scholar
• Borowitz D Lin R Baker SS Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency J Pediatr Gastroenterol Nutr 2007 44 2 219 223 17255835
   PubMed Web of Science ®Google Scholar
• Walkowiak J Nousia-Arvanitakis S Agguridaki C Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test J Pediatr Gastroenterol Nutr 2003 36 4 474 478 12658038
   PubMed Web of Science ®Google Scholar
• Castellani C Cuppens H Macek MJr Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice J Cyst Fibros 2008 7 3 179 196 18456578
   PubMed Web of Science ®Google Scholar
• Wier HA Kuhn RJ Pancreatic enzyme supplementation Curr Opin Pediatr 2011 23 5 541 544 21799412
   PubMed Web of Science ®Google Scholar
• Giuliano CA Dehoorne-Smith ML Kale-Pradhan PB Pancreatic enzyme products: digesting the changes Ann Pharmacother 2011 45 5 658 666 21540403
   PubMed Web of Science ®Google Scholar
• Graff GR Maguiness K McNamara J Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study Clin Ther 2010 32 1 89 103 20171415
   PubMed Web of Science ®Google Scholar
• Graff GR McNamara J Royall J Caras S Forssmann K Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study Clin Drug Investig 2010 30 6 351 364
   Web of Science ®Google Scholar
• Trapnell BC Maguiness K Graff GR Boyd D Beckmann K Caras S Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis J Cyst Fibros 2009 8 6 370 377 19815466
   PubMed Web of Science ®Google Scholar
• Wooldridge JL Heubi JE Amaro-Galvez R EUR-1008 pan-creatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency J Cyst Fibros 2009 8 6 405 417 19683970
   PubMed Web of Science ®Google Scholar
• Borowitz DS Grand RJ Durie PR Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy Consensus Committee J Pediatr 1995 127 5 681 684
   Google Scholar
• Colombo C Fredella C Russo MC Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study Pancreas 2009 38 6 693 699 19531972
   PubMed Web of Science ®Google Scholar
• Kalnins D Ellis L Corey M Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis J Pediatr Gastroenterol Nutr 2006 42 3 256 261 16540792
   PubMed Web of Science ®Google Scholar
• Brady MS Garson JL Krug SK An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study J Am Diet Assoc 2006 106 8 1181 1186 16863712
   PubMedGoogle Scholar
• Borowitz D Konstan M O’Rourke A Cohen M Hendeles L Murray FT Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis Journal of Pediatric Pharmacology and Therapeutics 2007 12 47 52
   Google Scholar
• Borowitz D Stevens C Brettman LR Campion M Chatfield B Cipolli M International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients J Cyst Fibros 2011 10 6 443 452 21831726
   PubMed Web of Science ®Google Scholar
• Borowitz D Stevens C Brettma LR Campion M Wilschanski M Thompson H International open-label trial of liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis patients J Pediatr Gastroenterol Nutr 8 26 2011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Durie P Kalnins D Ellis L Uses and abuses of enzyme therapy in cystic fibrosis J R Soc Med 1998 91 Suppl 34 2 13 9709382
   PubMed Web of Science ®Google Scholar
• Butt AM Ip W Ellis L The fate of exogenous enzymes in patients with cystic fibrosis and pancreatic insufficiency (Abstr) J Pediatr Gastroenterol Nutr 2001 33 391
   Google Scholar
• Kalivianakis M Minich DM Bijleveld CM Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids Am J Clin Nutr 1999 69 1 127 134 9925134
   PubMed Web of Science ®Google Scholar
• Laiho KM Gavin J Murphy JL Connett GJ Wootton SA Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis Clin Nutr 2004 23 3 347 353 15158298
   PubMed Web of Science ®Google Scholar
• Bower TR Pringle KC Soper RT Sodium deficit causing decreased weight gain and metabolic acidosis in infants with ileostomy J Pediatr Surg 1988 23 6 567 572 2843619
   PubMed Web of Science ®Google Scholar
• Bianchi ML Romano G Saraifoger S Costantini D Limonta C Colombo C BMD and body composition in children and young patients affected by cystic fibrosis J Bone Miner Res 2006 21 3 388 396 16491286
   PubMed Web of Science ®Google Scholar
• Buntain HM Greer RM Schluter PJ Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study Thorax 2004 59 2 149 155 14760157
   PubMed Web of Science ®Google Scholar
• Gronowitz E Garemo M Lindblad A Mellstrom D Strandvik B Decreased bone mineral density in normal-growing patients with cystic fibrosis Acta Paediatr 2003 92 6 688 693 12856979
   PubMed Web of Science ®Google Scholar
• Aris RM Merkel PA Bachrach LK Guide to bone health and disease in cystic fibrosis J Clin Endocrinol Metab 2005 90 3 1888 1896 15613415
   PubMed Web of Science ®Google Scholar
• Moran A Brunzell C Cohen RC Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society Diabetes Care 2010 33 12 2697 2708 21115772
   PubMed Web of Science ®Google Scholar
• Cheung MS Bridges NA Prasad SA Growth in children with cystic fibrosis-related diabetes Pediatr Pulmonol 2009 44 12 1223 1225 19894249
   PubMed Web of Science ®Google Scholar
• Hameed S Morton JR Field PI Once daily insulin detemir in cystic fibrosis with insulin deficiency Arch Dis Child 4 14 2011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Kolouskova S Zemkova D Bartosova J Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study J Pediatr Endocrinol Metab 2011 24 7–8 449 454 21932580
   PubMed Web of Science ®Google Scholar
• Phung OJ Coleman CI Baker EL Recombinant human growth hormone in the treatment of patients with cystic fibrosis Pediatrics 2010 126 5 e1211 e1226 20921071
   PubMed Web of Science ®Google Scholar
• Stalvey MS Anbar RD Konstan MW A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis Pediatr Pulmonol 9 8 2011 [Epub ahead of print.]
   Google Scholar
• Chinuck RS Fortnum H Baldwin DR Appetite stimulants in cystic fibrosis: a systematic review J Hum Nutr Diet 2007 20 6 526 537 18001374
   PubMed Web of Science ®Google Scholar
• Edenborough FP Borgo G Knoop C Guidelines for the management of pregnancy in women with cystic fibrosis J Cyst Fibros 2008 7 Suppl 1 S2 S32 18024241
   PubMed Web of Science ®Google Scholar
• Goss CH Rubenfeld GD Otto K Aitken ML The effect of pregnancy on survival in women with cystic fibrosis Chest 2003 124 4 1460 1468 14555580
   PubMed Web of Science ®Google Scholar
• Schwebel C Pin I Barnoud D Prevalence and consequences of nutritional depletion in lung transplant candidates Eur Respir J 2000 16 6 1050 1055 11292104
   PubMed Web of Science ®Google Scholar
• Aris RM Neuringer IP Weiner MA Egan TM Ontjes D Severe osteoporosis before and after lung transplantation Chest 1996 109 5 1176 1183 8625663
   PubMed Web of Science ®Google Scholar
• Daniels MW Wilson DM Paguntalan HG Hoffman AR Bachrach LK Bone mineral density in pediatric transplant recipients Transplantation 2003 76 4 673 678 12973107
   PubMed Web of Science ®Google Scholar
• McPartland KJ Pomposelli JJ Update on immunosuppressive drugs used in solid-organ transplantation and their nutrition implications Nutr Clin Pract 2007 22 5 467 473 17906270
   PubMed Web of Science ®Google Scholar
• Ollech JE Kramer MR Peled N Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors Eur J Cardiothorac Surg 2008 33 5 844 848 18339554
   PubMed Web of Science ®Google Scholar
• Stephenson A Brotherwood M Robert R Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation Transplantation 2005 79 5 613 615 15753854
   PubMed Web of Science ®Google Scholar
• Ho T Gupta S Brotherwood M Increased serum vitamin A and E levels after lung transplantation Transplantation 2011 92 5 601 606 21841542
   PubMed Web of Science ®Google Scholar
• Stiebellehner L Quittan M End A Aerobic endurance training program improves exercise performance in lung transplant recipients Chest 1998 113 4 906 912 9554624
   PubMed Web of Science ®Google Scholar
• Houwen RH van der Doef HP Sermet I Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS J Pediatr Gastroenterol Nutr 2010 50 1 38 42 19525866
   PubMed Web of Science ®Google Scholar
• Colombo C Ellemunter H Houwen R Munck A Taylor C Wilschanski M Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients J Cyst Fibros 2011 10 Suppl 2 S24 S28 21658638
   PubMed Web of Science ®Google Scholar